Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #134113 on Anavex Life Sciences Corp (AVXL)
nidan7500
12/13/17 8:08 AM
#134114 RE: Investor2014 #134113
12/13/17 8:28 AM
#134118 RE: Investor2014 #134113
We have filed an investigational new drug application, or IND, for ANAVEX®2-73 for the treatment of Rett syndrome and are currently in preparation for a Phase 2 clinical trial. The IND might not be approved by the FDA, or it may be delayed or put on clinical hold or partial hold, or additional preclinical studies may be required.